1. Epigenetics Metabolic Enzyme/Protease Vitamin D Related/Nuclear Receptor
  2. Histone Methyltransferase 11β-HSD Androgen Receptor
  3. SJL2-1

SJL2-1 is a PRMT5 inhibitor, with an IC50 of 1.56 μM. SJL2-1 suppresses proliferation, migration, and invasion in prostate cancer cells. SJL2-1 promotes apoptosis and blocks the cell cycle at the G0/G1 phase. SJL2-1 can target the binding of PRMT5 in cells and inhibit the methylation and expression of the androgen receptor. SJL2-1 can be used for the study of early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC).

For research use only. We do not sell to patients.

SJL2-1 Chemical Structure

SJL2-1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SJL2-1 is a PRMT5 inhibitor, with an IC50 of 1.56 μM. SJL2-1 suppresses proliferation, migration, and invasion in prostate cancer cells. SJL2-1 promotes apoptosis and blocks the cell cycle at the G0/G1 phase. SJL2-1 can target the binding of PRMT5 in cells and inhibit the methylation and expression of the androgen receptor. SJL2-1 can be used for the study of early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC)[1].

In Vitro

SJL2-1 (2.96-60 μM, 24-96 h) suppresses proliferation, migration, and invasion in prostate cancer cells including 22RV1, PC-3, and LNCaP cells[1].

SJL2-1 (15-45 μM, 48 h) promotes apoptosis and blocks the cell cycle at the G0/G1 phase in prostate cancer cells including 22RV1, PC-3, and LNCaP cells[1].

SJL2-1 (15-45 μM) inhibits PRMT5 expression, reduces downstream SDMA levels and SmD3me2S protein expression, and decreases the androgen receptor expression in 22RV1, PC-3, and LNCaP cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: PC3, 22RV1, and LNCaP cells
Concentration: 1-60 μM
Incubation Time: 24, 48, 72, 96 h
Result: Showed the anti-proliferation in PC-3 cells with IC50s of 46.11 μM (24 h), 37.29 μM (48 h), 32.74 μM (72 h) and 26.24 μM (96 h).
Showed the anti-proliferation in 22RV1 cells with IC50s of 44.31 μM (24 h), 40.07 μM (48 h), 33.41 μM (72 h) and 26.09 μM (96 h).
Showed the anti-proliferation in LNCAP cells with IC50s of 5.92 μM (24 h), 4.29 μM (48 h), 4.68 μM (72 h) and 4.45 μM (96 h).

Immunofluorescence[1]

Cell Line: PC3, 22RV1, and LNCaP cells
Concentration: 23.055 μM (PC3 cells), 22.155 μM (22RV1 cells), 2.96 μM (LNCAP cells)
Incubation Time: 24 h
Result: Inhibited cell proliferation and reduced active DNA replication in 5-Ethynyl-2’-Deoxyuridine(EdU) (HY-118411) incorporation assay.

Cell Migration Assay [1]

Cell Line: PC3, 22RV1, and LNCaP cells
Concentration: 23.055 μM (PC3 cells), 22.155 μM (22RV1 cells), 2.96 μM (LNCAP cells)
Incubation Time: 48 h
Result: Reduced the number of migratory cells in PC-3, 22RV1, and LNCaP cells.

Cell Invasion Assay[1]

Cell Line: PC3, 22RV1, and LNCaP cells
Concentration: 23.055 μM (PC3 cells), 22.155 μM (22RV1 cells), 2.96 μM (LNCAP cells)
Incubation Time: 48 h
Result: Suppressed cell invasion ability in PC3, 22RV1, and LNCaP cells.

Cell Cycle Analysis[1]

Cell Line: PC-3, 22RV1, and LNCaP cells
Concentration: 15, 30, 45 μM
Incubation Time: 48 h
Result: Impeded the progression of 22RV1, PC3, and LNCAP cells to the G1 phase in a dose-dependent manner, with a significant accumulation of cells in the G0/G1 phase and a concomitant decrease in the number of cells in the G2 phase.

Western Blot Analysis[1]

Cell Line: PC3, 22RV1, and LNCaP cells
Concentration: 15, 30 , 45 μM
Incubation Time: 48 h
Result: Upregulated the pro-apoptotic effector Bax and elevated levels of both caspase-3 concentration-dependently.
Molecular Weight

334.45

Formula

C22H26N2O

SMILES

CC1=CN(CC(CN2C(C)C(C=CC=C3)=C3CC2)O)C4=CC=CC=C41

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SJL2-1
Cat. No.:
HY-174908
Quantity:
MCE Japan Authorized Agent: